MMWR News Synopsis
Thursday, May 31, 2018
CDC Media Relations
Substantial progress has been made towards rubella and congenital rubella syndrome (CRS) control in the South-East Asia Region since 2000, with a 37 percent decrease in reported regional rubella incidence following introduction of rubella containing vaccine (RCV) in six additional countries, achievement of high routine RCV coverage after introduction, and enhancement of laboratory-supported surveillance. In 2013, the 66th session of the Regional Committee of the World Health Organization (WHO) South-East Asia Region (SEAR) adopted the goal of measles elimination and rubella and CRS control by 2020. Rubella infection is the leading vaccine-preventable cause of birth defects. Infection during pregnancy, especially during the first trimester, can result in miscarriage, fetal death, or a constellation of congenital malformations known as CRS. Substantial progress has been made towards rubella and CRS control in SEAR since 2000. During 2010-2016, reported rubella incidence decreased by 37 percent across the region. This report summarizes progress toward rubella and CRS control in SEAR during 2000–2016.
- Outbreak of Severe Illness Linked to the Vitamin K Antagonist Brodifacoum and Use of Synthetic Cannabinoids – Illinois, March-April 2018
- Cyclosporiasis Cases Associated with Dining at a Mediterranean-Style Restaurant Chain – Texas, 2017
- Verona Integron-Encoded Metallo-Beta-Lactamase Producing Pseudomonas Aeruginosa Outbreak in a Long-Term Acute Care Hospital – Orange County, Florida, 2017
CDC works 24/7 protecting America’s health, safety and security. Whether diseases start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.